This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Jukka Gynther: Innovator in Prolyl Oligopeptidase Inhibitors
Introduction
Jukka Gynther is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit prolyl oligopeptidase activity. His work is particularly relevant for therapeutic applications, including the treatment of Alzheimer's disease.
Latest Patents
Jukka Gynther holds a patent for "Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use." This patent describes compounds of the formula (I), where the symbol aa represents a residue of an α-amino acid. The invention outlines methods for preparing these compounds and their potential use as prolyl oligopeptide inhibitors.
Career Highlights
Gynther is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on innovative solutions for complex health issues, particularly neurodegenerative diseases.
Collaborations
Some of Jukka Gynther's notable coworkers include Pekka Männistö and Erik Wallen. Their collaborative efforts contribute to the advancement of research and development in the field of medicinal chemistry.
Conclusion
Jukka Gynther's innovative work in developing prolyl oligopeptidase inhibitors showcases his commitment to addressing critical health challenges. His contributions are vital for the ongoing research in treatments for Alzheimer's disease and other related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile